Release date: 12/15/2022
Expiration date: 12/15/2023
Program Overview: A non-accredited educational activity to summarize the current treatment options for pulmonary artery disease.
Target Audience: Cardiologists, pulmonologists, nurse practitioners, physician assistants, nurses and other providers involved in the management of patients with pulmonary arterial hypertension (PAH)
Summarize current treatment options for pulmonary arterial hypertension.
Deborah C. Clark, PhD Senior Director of Professional Development
Supported by an educational grant from Merck Sharp & Dohme LLC a subsidiary of Merck & Co., Inc.